Puma Biotechnology
Stock Forecast, Prediction & Price Target
Puma Biotechnology Financial Estimates
Puma Biotechnology Revenue Estimates
Puma Biotechnology EBITDA Estimates
Puma Biotechnology Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $253.2M N/A | $228M -9.95% | $235.63M 3.34% | Avg: $225.05M Low: $221.71M High: $230.10M avg. -4.49% | Avg: $229.8M Low: $221.97M High: $237.37M avg. 2.11% | Avg: $205M Low: $198.02M High: $211.75M avg. -10.79% | Avg: $200M Low: $193.19M High: $206.58M avg. -2.43% |
Net Income
% change YoY
| $-29.1M N/A | $912K 103.13% | $21.59M 2267.43% | Avg: $15.1M Low: $4.75M High: $24.72M avg. -30.06% | Avg: $15.55M Low: $14.54M High: $15.86M avg. 2.98% | Avg: $-7.13M Low: $-7.43M High: $-6.81M avg. -145.86% | Avg: $-11.88M Low: $-12.39M High: $-11.36M avg. -66.66% |
EBITDA
% change YoY
| $1.7M N/A | $31.5M 1752.94% | $47.52M 50.86% | Avg: $3.20M Low: $3.16M High: $3.28M avg. -93.24% | Avg: $3.27M Low: $3.16M High: $3.38M avg. 2.11% | Avg: $2.92M Low: $2.82M High: $3.01M avg. -10.79% | Avg: $2.85M Low: $2.75M High: $2.94M avg. -2.43% |
EPS
% change YoY
| -$0.72 N/A | $0.02 102.83% | $0.46 2154.90% | Avg: $0.24 Low: $0.1 High: $0.52 avg. -47.17% | Avg: $0.32 Low: $0.31 High: $0.33 avg. 31.68% | Avg: -$0.15 Low: -$0.16 High: -$0.14 avg. -146.87% | Avg: -$0.25 Low: -$0.26 High: -$0.24 avg. -66.66% |
Operating Expenses
% change YoY
| $188.2M N/A | $142.2M -24.44% | $140.31M -1.32% | Avg: $102.59M Low: $101.07M High: $104.90M avg. -26.88% | Avg: $104.76M Low: $101.19M High: $108.21M avg. 2.11% | Avg: $93.45M Low: $90.27M High: $96.53M avg. -10.79% | Avg: $91.17M Low: $88.07M High: $94.18M avg. -2.43% |
FAQ
What is Puma Biotechnology stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -59.90% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is 4.75M, average is 15.1M and high is 24.72M.
What is Puma Biotechnology stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -3.90% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $221.71M, average is $225.05M and high is $230.10M.
What is Puma Biotechnology stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -57.25% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is $0.1, average is $0.24 and high is $0.52.